Literature DB >> 3023895

Transformation of chicken embryo fibroblasts and tumor induction by the middle T antigen of polyomavirus carried in an avian retroviral vector.

S Kornbluth, F R Cross, M Harbison, H Hanafusa.   

Abstract

The middle T antigen of polyomavirus transformed primary chicken embryo fibroblasts when expressed from a replication-competent avian retrovirus. This in vitro-constructed retrovirus, SRMT1, is a variant of Rous sarcoma virus that encodes the middle T antigen in place of v-src. Inoculation of SRMT1 into 1-week-old chickens rapidly induced hemangiomas and hemangiosarcomas. As shown with mammalian cells infected with polyomavirus, polyomavirus middle T antigen appears to be associated with p60c-src in chicken cells infected with SRMT1. When lysates of SRMT1-infected cells immunoprecipitated with either a monoclonal antibody against p60src or anti-T serum were assayed in an in vitro kinase reaction, the middle T antigen was heavily phosphorylated. To see whether an excess of p60c-src could alter the extent of phosphorylation of the middle T protein or the process of cell transformation by middle T, cells were doubly infected with SRMT1 and NY501, a virus which overexpresses p60c-src. Doubly infected chicken embryo fibroblasts transformed with the same kinetics and were morphologically indistinguishable from chicken embryo fibroblasts infected with SRMT1 alone. Phosphorylation of the middle T antigen was elevated two- to fivefold relative to cells infected only with SRMT1.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3023895      PMCID: PMC367680          DOI: 10.1128/mcb.6.5.1545-1551.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  THE NATURE OF THE HEMORRHAGIC LESIONS INDUCED BY POLYOMA VIRUS IN HAMSTERS.

Authors:  V DEFENDI; J M LEHMAN
Journal:  Cancer Res       Date:  1964-02       Impact factor: 12.701

2.  Polyoma virus-specific 55K protein isolated from plasma membrane of productively infected cells is virus-coded and important for cell transformation.

Authors:  Y Ito
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

3.  Protein kinase activity associated with polyoma virus middle T antigen in vitro.

Authors:  A E Smith; R Smith; B Griffin; M Fried
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

4.  Sequences from the genome of a non-transforming mutant of polyoma virus.

Authors:  E Soeda; B E Griffin
Journal:  Nature       Date:  1978-11-16       Impact factor: 49.962

5.  Host range selection of transformation-defective hr-t mutants of polyoma virus.

Authors:  R J Staneloni; M M Fluck; T L Benjamin
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

6.  Tumor antigen(s) in cell productively infected by wild-type polyoma virus and mutant NG-18.

Authors:  B S Schaffhausen; J E Silver; T L Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

7.  Mechanism of transfection of chicken embryo fibroblasts by Rous sarcoma virus DNA.

Authors:  G M Cooper; S Okenquist
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

8.  Rapid transformation of cells by Rous sarcoma virus.

Authors:  H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

9.  DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel; G Urlaub; L Chasin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

10.  Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus.

Authors:  Y Ito; J R Brocklehurst; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  35 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  Replication-competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells.

Authors:  C J Petropoulos; S H Hughes
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons.

Authors:  T Grussenmeyer; A Carbone-Wiley; K H Scheidtmann; G Walter
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation.

Authors:  B J Mayer; H Hanafusa
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

5.  Two point mutations in the transmembrane domain of P68gag-ros inactive its transforming activity and cause a delay in membrane association.

Authors:  S M Jong; L H Wang
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

Review 6.  Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Authors:  Michele M Fluck; Brian S Schaffhausen
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

7.  A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity.

Authors:  B J Druker; L E Ling; B Cohen; T M Roberts; B S Schaffhausen
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Characterization of pp85, a target of oncogenes and growth factor receptors.

Authors:  B Cohen; Y X Liu; B Druker; T M Roberts; B S Schaffhausen
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

9.  The amino terminus of polyomavirus middle T antigen is required for transformation.

Authors:  D N Cook; J A Hassell
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

10.  Cooperation of middle and small T antigens of polyomavirus in transformation of established fibroblast and epithelial-like cell lines.

Authors:  T Noda; M Satake; Y Yamaguchi; Y Ito
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.